Newsletters
-
PD for Tue 28 Oct 2014
Tuesday | Oct 28 2014CSL buys Novartis vax, Guild condolences, Diabetes impact under-reported, Zovirax retail recall, and much more.
-
PD for Mon 27 Oct 2014
Monday | Oct 27 2014Pharm prof leads regs review, Three diseases cause 1/3 deaths, $555m Soliris sales, Kalydeco PBS list, and much more.
-
PD for Fri 24 Oct 2014
Friday | Oct 24 2014Fred IT: business as usual, Blackmores $8.7m profit, PSA course vax tick, Pharmacy Board applications, and much more.
-
PD for Thu 23 Oct 2014
Thursday | Oct 23 2014API: $31.7m underlying profit, ACCC focuses on cosmetics, Health CPI up 4.7%, NPS: ROI is 2:1, and much more.
-
PD for Wed 22 Oct 2014
Wednesday | Oct 22 2014QPIP wins Innovative award, Advanced practice consultation, Pharma disclosure hailed by CHF, Health, Beauty and New Products, and much more.
-
PD for Tue 21 Oct 2014
Tuesday | Oct 21 2014Adverse reports down, Save $2b by treating at pharmacy, Pharmacy assistant of the year, Letter to the Editor, and much more.
-
PD for Mon 20 Oct 2014
Monday | Oct 20 2014All pharma pay reported, Sedrak decision, OTC sildenafil in NZ, Senior academic wins 'Man of the Match', and much more.
-
PD for Fri 17 Oct 2014
Friday | Oct 17 2014Patients choose generic, Guardian wins again, Vital Signs 2014, Letter to the Editor, and much more.
-
PD for Thu 16 Oct 2014
Thursday | Oct 16 2014Comp report 'not Crusoe', 25% expectations not met, CPD by the SEA consolidated, AMA fights back, and much more.
-
PD for Wed 15 Oct 2014
Wednesday | Oct 15 2014Vic recommendations welcomed, $1.8b benefit from CMs, $188.5m for industry centres, Health & Beauty and much more.